Japan Plans Incentives To Pharmacists To Push Generic Drugs (Japan)
This article was originally published in PharmAsia News
Japan's health ministry plans to begin next April providing incentives to pharmacists to get them to push generic versions instead of brand-name drugs. An official says the government, as part of a medical cost-cutting effort, has drafted the plan to be included in a broader review of its medical service fee system. The incentive involves offering pay to pharmacists whose generics sales are at least 30 percent of the medicines they sell. The ministry expects health care spending to grow by 74 percent by 2025. (Click here for more ) "Japan Plans Generic Drug Incentives: Ministry" China Post (Taiwan) (12/7/07)
You may also be interested in...
Japan's Ministry of Health, Labor and Welfare will send a research group to the U.S., U.K. and France in February, to study price setting and logistical systems being used in the pharmaceutical industries there, the MHLW announced Jan. 29.The research will focus on how to promote generic drugs in Japan to bring new ideas to the drug re-pricing discussions in April, said the MHLW
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.